<DOC>
	<DOC>NCT01068964</DOC>
	<brief_summary>This study will evaluate the safety and efficacy of once daily administered 0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution compared with once daily administered 0.03% Bimatoprost Ophthalmic Solution and once daily administered 0.5% Timolol Ophthalmic Solution concurrently in patients with open-angle glaucoma or ocular hypertension</brief_summary>
	<brief_title>Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Diagnosis of openangle glaucoma or ocular hypertension in one or both eyes Eye pressure lowering topical medications are not working Visual acuity is at least 0.2 in each eye Uncontrolled systemic disease Any other active eye disease other than glaucoma or ocular hypertension Significant visual field loss or evidence of progressive visual field loss within the last year Anticipated wearing of contact lenses during the study Required chronic use of other ocular medications during the study Eye surgery or laser treatment within 12 weeks prior to study enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2014</verification_date>
</DOC>